BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8961807)

  • 1. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical animal studies with radioiododeoxyuridine.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
    Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
    Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
    Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
    Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical modulation by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 5-[123I]iodo-2'deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G; Di Sacco S; Bonini R; Di Luca L; Buralli S; Bonora D; Ricci S; Baranowska-Kortylewicz J; Adelstein SJ; Falcone A; Kassis AI
    Acta Oncol; 1996; 35(7):941-5. PubMed ID: 9004775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
    Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ
    J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-[125]iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats.
    Kassis AI; Adelstein SJ
    Acta Oncol; 1996; 35(7):935-9. PubMed ID: 9004774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
    Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies.
    Schneiderman MH; Schneiderman GS
    J Nucl Med; 1996 Apr; 37(4 Suppl):6S-9S. PubMed ID: 8676203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for tumor therapy with iodine-125 labeled immunoglobulins.
    Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S
    Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled iododeoxyuridine: safety evaluation.
    Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
    J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.
    Mariani G; Cei A; Collecchi P; Baranowska-Kortylewicz J; Van den Abbeele AD; Di Luca L; Di Stefano R; Viacava P; Ferdeghini EM; Di Sacco S
    J Nucl Med; 1993 Jul; 34(7):1175-83. PubMed ID: 8315499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.
    Vaidyanathan G; Larsen RH; Zalutsky MR
    Cancer Res; 1996 Mar; 56(6):1204-9. PubMed ID: 8640798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.
    Kinsella TJ; Kunugi KA; Vielhuber KA; Potter DM; Fitzsimmons ME; Collins JM
    Clin Cancer Res; 1998 Jan; 4(1):99-109. PubMed ID: 9516958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
    Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
    Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.